相关实验视频
Updated: Jun 27, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.1K
炎症性肠病背后的机制,其治疗和淋巴瘤风险之间的复杂关系:综合性审查
Katarzyna Stasik1, Rafał Filip2
1Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, 35-301 Rzeszow, Poland.
International journal of molecular sciences
|April 27, 2024
概括
患有炎症性肠道疾病 (IBD) 的患者面临淋巴瘤风险增加,这可能与提奥普林或抗瘤坏死因子 (anti-TNF) 药物有关. 由于缺乏明确的治疗指南,管理具有活性淋巴瘤或癌症史的IBD存在重大临床挑战.
科学领域:
- 胃肠道学和瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 患者表现出淋巴瘤和胃肠道癌症的风险较高.
- 提奥普林和抗瘤坏死因子 (抗TNF) 疗法可能与这些瘤病理有关.
- 慢性炎症和病毒感染与IBD患者的癌症发生过程有关.
研究的目的:
- 检查治疗IBD患者活跃淋巴瘤或血液癌症病史的临床问题.
- 探索克罗恩氏病患者的治疗策略,这些患者之前已经被诊断为淋巴瘤.
- 为了确定淋巴增殖性疾病和自身免疫性疾病之间的共同点.
主要方法:
- 审查关于IBD治疗的现有文献.
- 分析慢性炎症和病毒感染对癌症发展的影响.
- 考虑患者淋巴瘤和淋巴增殖性疾病病史的治疗选择的讨论.
主要成果:
- 肠胃炎症患者患淋巴瘤和肠胃癌的风险更高.
- 治疗方法如硫素和抗TNF药物可能会增加这种风险.
- 淋巴瘤发生的风险很大,特别是在有淋巴增殖性疾病病史的患者中.
结论:
- 治疗IBD患者有活跃淋巴瘤或癌症病史是具有挑战性的.
- 在有淋巴瘤病史的患者中,缺乏明确的指导方针来管理克罗恩病.
- 需要进一步的研究,以建立最佳的治疗方法和风险分层.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease I: Ulcerative Colitis
172
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
172
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Inflammatory Bowel Disease II: Crohn's Disease
222
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
222
Chronic Bowel Disorders: Introduction
446
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
446
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160

